Author

Ana Paula Lacerda 1

1 AbbVie, North Chicago, United States

CORRELATION OF BIOMARKERS OF INFLAMMATION WITH CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: DATA FROM CELEST

Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Silvio Danese, Simon Travis, Gerald Dryden, Robert Hardi, Michael S Epstein, Wen Zhou, Fabio Cataldi, Bidan Huang, Ana Paula Lacerda, Julian Panés

EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U-EXCEL STUDY

Edward V. Loftus, Jean-Frédéric Colombel, Ana Paula Lacerda, Laurent Peyrin-Biroulet, Geert R. D'Haens, Remo Panaccione, Walter Reinisch, Edouard Louis, Minhu Chen, Hiroshi Nakase, Susan Greenbloom, Aaron Duvall, Yuri Sanchez Gonzalez, Mohamed-Eslam F. Mohamed, Susan Rhee, Tian Feng, Elena Dubcenco, Julian Panés

Item 1 - 2 / 2
1